業績紹介
英語論文
私の大学病院・総合病院勤務時の基礎・臨床研究にご興味のある方は下記PubMed(パブメド)リンクをご参照ください。
PubMedとは、アメリカ国立医学図書館の国立生物工学情報センター(NCBI)が運営する医学・生物学分野の学術文献検索サービスです。
以下は私が筆頭著者あるいは責任著者のみを抜粋しております。
1.
TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis. Matsubara T, Kanto T, Kuroda S, Yoshio S, Higashitani K, Kakita N, Miyazaki M, Sakakibara M, Hiramatsu N, Kasahara A, Tomimaru Y, Tomokuni A, Nagano H, Hayashi N, Takehara T. Hepatology. 2013 Apr;57(4):1416-25.
2.
Histological complete response in a patient with advanced biliary tract cancer treated by gemcitabine/cisplatin/S-1 combination chemotherapy: A case report. Matsubara T, Nishida T, Tomimaru Y, Yamamoto M, Hayashi S, Nakajima S, Fukui K, Dono K, Adachi S, Ioka T, Kanai M, Inada M. Mol Clin Oncol. 2016 Dec;5(6):757-761.
3.
The combination of anti-HBc and anti-HBs levels is a useful predictor of the development of chemotherapy-induced reactivation in lymphoma patients with resolved HBV infection. Matsubara T, Nishida T, Shimoda A, Shimakoshi H, Amano T, Sugimoto A, Takahashi K, Mukai K, Yamamoto M, Hayashi S, Nakajima S, Fukui K, Inada M. Oncol Lett. 2017 Dec;14(6):6543-6552.
4.
Clinically diagnosed late-onset fulminant Wilson's disease without cirrhosis: A case report. Amano T, Matsubara T, Nishida T, Shimakoshi H, Shimoda A, Sugimoto A, Takahashi K, Mukai K, Yamamoto M, Hayashi S, Nakajima S, Fukui K, Inada M. World J Gastroenterol. 2018 Jan 14;24(2):290-296.
5.
Nivolumab Induces Sustained Liver Injury in a Patient with Malignant Melanoma. Matsubara T, Nishida T, Higaki Y, Tomita R, Shimakoshi H, Shimoda A, Osugi N, Sugimoto A, Takahashi K, Nakamatsu D, Mukai K, Yamamoto M, Fukui K, Adachi S, Inada M. Intern Med. 2018 Jun 15;57(12):1789-1792.
6.
Prediction and clinical implications of HBV reactivation in lymphoma patients with resolved HBV infection: focus on anti-HBs and anti-HBc antibody titers. Nishida T, Matsubara T, Yakushijin T, Inada M. Hepatol Int. 2019 Jul;13(4):407-415.
7.
Comparison of double-layer large-diameter and conventional small-diameter plastic stents for preoperative biliary drainage in resectable distal malignant biliary obstruction. Matsubara T, Nishida T, Hayashi S, Shimakoshi H, Tomimaru Y, Takahashi K, Nakamatsu D, Matsumoto K, Yamamoto M, Inada M. Sci Rep. 2020 Aug 6;10(1):13222.
8.
The effectiveness of a nonalcoholic disinfectant containing metal ions, with broad antimicrobial activity. Matsubara T, Maki S, Toshimori Y. Sci Rep. 2021 Jan 13;11(1):1072.
MENU
国際学会発表
以下は私が筆頭発表実績のみを掲載しております。
2010年 AASLD(米国肝臓病学会)
PRO-ANGIOGENIC RECEPTOR TIE2-EXPRESSING MONOCYTES/TEMS AS NOVEL DIAGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA
2010年 HCV国際学会関連2010
Pro-angiogenic receptor Tie2-expressing monocytes/TEMs as a novel diagnostic marker for HCV infected hepatocellular carcinoma
2011年 AASLD(米国肝臓病学会)
PRO-ANGIOGENIC RECEPTOR TIE2-EXPRESSING MONOCYTES/TEM AS NOVEL DIAGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA
2012年 AASLD(米国肝臓病学会)
TIE2-expressing monocytes are feasible angiogenesis-related cellular diagnostics for hepatocellular carcinoma: involvement of inflammatory cytokines in the generation
2017年 APDW(アジア太平洋消化器病週間)
The combination of anti-HBc and anti-HBs levels is a useful predictor of the development of chemotherapy-induced reactivation in lymphoma patients with resolved HBV infection
受賞歴
2012年10月
第3回 Bristol-Myers Award(第16回 日本肝臓学会大会)受賞
TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlated with angiogenesis
2014年2月
大阪大学消化器内科学同窓会 臨床研究賞
TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlated with angiogenesis
2018年2月
大阪大学消化器内科学同窓会 症例報告賞
全身化学療法(GCS療法)が著効し組織学的CRが得られた大動脈周囲リンパ節転移を伴った肝門部領域胆管癌の1切除例
2018年3月
市立豊中病院 臨床研究奨励賞
The combination of anti-HBc and anti-HBs levels is a useful predictor of the development of chemotherapy-induced reactivation in lymphoma patients with resolved HBV infection